TUG1 Suppression Boosts Immunity and Lenvatinib in Liver Cancer
Hepatocellular carcinoma (HCC) remains one of the deadliest malignancies worldwide, with limited therapeutic options and a poor prognosis that continues ...
Tag: targeted therapy for liver cancer
Scientists Identify Novel Genetic Target Poised to Transform Liver Cancer Therapy
Hepatocellular carcinoma (HCC) is one of the most formidable challenges in oncology today. Representing the predominant form of liver cancer ...
Mitochondrial Protein Shows Promise for Targeted Liver Cancer Therapy
Liver cancer remains one of the most formidable challenges in oncology, with hepatocarcinoma—or hepatocellular carcinoma (HCC)—standing as its most commonly ...
Aurora Kinase Inhibition in Liver Cancer: A Dual Strategy to Halt Tumor Growth and Enhance Cell Differentiation
A groundbreaking study recently published in Science China Life Sciences has unveiled a compelling therapeutic avenue for liver cancer treatment ...
HRAS Regulation Mechanisms Predict Liver Cancer Prognosis
In a groundbreaking study published in BMC Cancer, researchers have uncovered critical insights into the role of the HRAS proto-oncogene ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!